Kindred Biosciences, Inc.
NGF Antagonists for Medical Use
Last updated:
Abstract:
Provided are various embodiments relating to TrkA ECD polypeptides from companion animal species that bind to NGF. Such polypeptides can be used in methods to treat NGF-induced condition related to chronic pain and/or inflammatory pain in companion animals, such as canines, felines, and equines.
Status:
Application
Type:
Utility
Filling date:
20 Mar 2020
Issue date:
2 Jun 2022